← FDA Drug Approvals (Drugs@FDA)

TOBRAMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2017-10-13

Drug application

FDA Application #

ANDA209554

Application type

Abbreviated New Drug Application (Generic)

Brand name

TOBRAMYCIN

Generic name

Tobramycin

Active ingredients

TOBRAMYCIN

Dosage form

SOLUTION

Route

INHALATION

Marketing status

Discontinued

Sponsor

PHARMOBEDIENT

First approval

2017-10-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown